Join the Amyotrophic Lateral Sclerosis group to help and get support from people like you.
Amyotrophic Lateral Sclerosis News
Related terms: ALS (amyotrophic lateral sclerosis), Amyotrophic Lateral Sclerosis (ALS), Lou Gehrig's Disease, Motor Neurone Disease, ALS
Lower Risk of ALS Seen for Men With High Levels of Physical Activity, Fitness
WEDNESDAY, June 26, 2024 – For men, high levels of physical activity and fitness are associated with reduced risk of amyotrophic lateral sclerosis (ALS), according to a study published online June...
Staying Fit Might Cut Men's Odds for ALS
THURSDAY, June 27, 2024 – The search for a cure for ALS has been elusive, but researchers may have identified a way to lower a man's risk in the long run. Staying fit and getting moderate levels of...
Chemicals Stored in Your Garage Could Raise Odds for ALS
MONDAY, April 15, 2024 – Volatile and toxic chemicals commonly stored in garages can increase the risk of amyotrophic lateral sclerosis (ALS). Gasoline or kerosene, gas-powered equipment and lawn...
Maker Is Pulling Controversial ALS Drug Relyvrio Off the Market
THURSDAY, April 4, 2024 (HealthDayNews) – Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued...
Some Recreational Activities Might Up Amyotrophic Lateral Sclerosis Risk
TUESDAY, March 26, 2024 – Recreational activities — including golfing, gardening or yard work, woodworking and hunting — may be associated with an increased risk of developing amyotrophic lateral scl...
ALS Drug Relyvrio May Be Pulled From Market
MONDAY, March 11, 2024 – Amylyx Pharmaceuticals announced Friday that the controversial amyotrophic lateral sclerosis (ALS) drug Relyvrio has failed to help patients in a large follow-up study;...
Poor Trial Results May Prompt Maker to Pull ALS Drug Relyvrio From Market
MONDAY, March 11, 2024 – Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals...
Poor Trial Results May Prompt Maker to Pull ALS Drug Relyvrio From Market
MONDAY, March 11, 2024 – Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals...
Elon Musk Says First Human Has Received Neuralink Brain Implant
WEDNESDAY, Jan. 31, 2024 – Elon Musk, co-founder of Neuralink, said this week that the company placed the first brain implant in a human over the weekend. In a statement posted on X, the platform ...
Study Confirms Link Between Smoking and ALS
TUESDAY, Jan. 30, 2024 – New research is helping confirm smoking as a risk factor for the devastating brain illness amyotrophic lateral sclerosis (ALS). ALS affects roughly 31,000 Americans each...
Blood Test Measures ALS Risk From Environmental Toxins
WEDNESDAY, Nov. 1, 2023 – Amyotrophic lateral sclerosis, better known as ALS, is debilitating and has no cure. Now, researchers at the University of Michigan have developed an environmental risk...
Experimental ALS Drug Will Not Be Approved
THURSDAY, Sept. 28, 2023 – An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for amyotrophic...
FDA Panel Says No to Experimental ALS Drug, NurOwn
THURSDAY, Sept. 28, 2023 – An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending, NurOwn, a stem cell-based experimental treatment for ALS. A...
ALS Robbed Her of Speech, But Technology Is Changing That
WEDNESDAY, Aug. 23, 2023 – Many people with Lou Gehrig’s disease, also called amyotrophic lateral sclerosis (ALS), first start to lose the ability to move their arms and legs. That's not Pat B...
FDA Grants Accelerated Approval for Qalsody (tofersen) for the Treatment of Amyotrophic Lateral Sclerosis Associated with a Mutation in the SOD1 Gene
CAMBRIDGE, Mass., April 25, 2023 (GLOBE NEWSWIRE) – Biogen Inc. (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) has approved Qalsody (tofersen) 100 mg/15mL injection...
Ask a question
To post your own question to this support group, sign in or create an account.